• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性髓性白血病患者中的 - 双转录本及不同多态性

Dual transcripts of - & different polymorphisms in chronic myeloid leukaemia patients.

作者信息

Nandagopalan S Rajashree, Kuila Nivedita, Biswas Sutapa, Pattnayak Naresh Chandra, Biswas Gyanashyam, Chakraborty Soumen

机构信息

Institute of Life Sciences, Bhubaneswar, Odisha, India.

Sparsh Hospital & Critical Care, Bhubaneswar, Odisha, India.

出版信息

Indian J Med Res. 2016 May;143(Supplement):S136-S141. doi: 10.4103/0971-5916.191816.

DOI:10.4103/0971-5916.191816
PMID:27748288
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5080923/
Abstract

BACKGROUND & OBJECTIVES: Chronic myeloid leukaemia is (CML) characterized by the presence of a hallmark chromosomal translocation, the Philadelphia chromosome. Although there are many reports available regarding the different variants of BCR-ABL in CML, we studied the co-expression of e13a2 and e14a2 transcripts and a few polymorphisms in CML patients.

METHODS

Molecular genetics approach was adapted to screen for polymorphisms, mutation and translocation in BCR, ABL kinase domain and BCR-ABL breakpoint region in 73 CML patients.

RESULTS

All eight patients with dual transcripts were found to harbour an exonic polymorphism (c.2700 T>C) and an intronic polymorphism (g.109366A>G) that were earlier reported to be associated with co-expression of both the transcripts. We also observed c.763G>A mutation in ABL kinase domain and two polymorphisms, c.2387 A>G and c.2736A>G in the BCR gene.

INTERPRETATION & CONCLUSIONS: Though our data support the previous findings that co-expression of BCR-ABL transcripts is due to the occurrence of exonic and intronic polymorphisms in the BCR gene, it also shows that the intronic polymorphism can arise without the linked exonic polymorphism. The occurrence of ABL kinase domain mutation is less frequent in Indian population.

摘要

背景与目的

慢性髓性白血病(CML)的特征是存在标志性染色体易位——费城染色体。尽管有许多关于CML中BCR-ABL不同变体的报道,但我们研究了CML患者中e13a2和e14a2转录本的共表达以及一些多态性。

方法

采用分子遗传学方法筛查73例CML患者的BCR、ABL激酶结构域和BCR-ABL断裂点区域的多态性、突变和易位。

结果

所有8例具有双转录本的患者均存在一个外显子多态性(c.2700 T>C)和一个内含子多态性(g.109366A>G),此前报道这两个多态性与两种转录本的共表达有关。我们还在ABL激酶结构域中观察到c.763G>A突变,以及BCR基因中的两个多态性,即c.2387 A>G和c.2736A>G。

解读与结论

尽管我们的数据支持先前的发现,即BCR-ABL转录本的共表达是由于BCR基因中外显子和内含子多态性的出现,但也表明内含子多态性可以在没有相关外显子多态性的情况下出现。ABL激酶结构域突变在印度人群中的发生率较低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd66/5080923/384dcfb53ff7/IJMR-143-136-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd66/5080923/04fdfd583751/IJMR-143-136-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd66/5080923/384dcfb53ff7/IJMR-143-136-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd66/5080923/04fdfd583751/IJMR-143-136-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd66/5080923/384dcfb53ff7/IJMR-143-136-g003.jpg

相似文献

1
Dual transcripts of - & different polymorphisms in chronic myeloid leukaemia patients.慢性髓性白血病患者中的 - 双转录本及不同多态性
Indian J Med Res. 2016 May;143(Supplement):S136-S141. doi: 10.4103/0971-5916.191816.
2
Dual transcription of b2a2 and b3a2 BCR-ABL transcripts in chronic myeloid leukaemia is confined to patients with a linked polymorphism within the BCR gene.慢性髓性白血病中b2a2和b3a2 BCR-ABL转录本的双重转录仅限于BCR基因内存在连锁多态性的患者。
Br J Haematol. 2002 Jun;117(4):875-7. doi: 10.1046/j.1365-2141.2002.03508.x.
3
The molecular biology of chronic myeloid leukaemia.慢性髓细胞白血病的分子生物学
Leukemia. 1996 May;10(5):751-6.
4
Initial diagnosis of chronic myelogenous leukemia based on quantification of M-BCR status using droplet digital PCR.基于使用液滴数字PCR对M-BCR状态进行定量分析的慢性髓性白血病的初步诊断。
Anal Bioanal Chem. 2016 Feb;408(4):1079-94. doi: 10.1007/s00216-015-9204-2. Epub 2015 Dec 2.
5
Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia.慢性髓细胞白血病的细胞遗传学和分子遗传学方面
Acta Haematol. 2002;108(4):180-202. doi: 10.1159/000065655.
6
Alu and translisin recognition site sequences flanking translocation sites in a novel type of chimeric bcr-abl transcript suggest a possible general mechanism for bcr-abl breakpoints.一种新型嵌合bcr-abl转录本中易位位点侧翼的Alu和转座酶识别位点序列提示了bcr-abl断点的一种可能的普遍机制。
Haematologica. 2000 Jan;85(1):40-6.
7
Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.达沙替尼:一种用于治疗慢性粒细胞白血病和费城染色体阳性急性淋巴细胞白血病的酪氨酸激酶抑制剂。
Clin Ther. 2007 Nov;29(11):2289-308. doi: 10.1016/j.clinthera.2007.11.005.
8
Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.伴有e6a2 BCR-ABL且对伊马替尼无反应的慢性粒细胞白血病:两例病例报告
Acta Haematol. 2009;122(1):11-6. doi: 10.1159/000230037. Epub 2009 Jul 29.
9
[Atypical BCR-ABL transcripts in patients with chronic myeloid leukemia--the scheme for the diagnosis and monitoring of minimal residual disease].[慢性髓性白血病患者的非典型BCR-ABL转录本——微小残留病的诊断和监测方案]
Przegl Lek. 2014;71(5):258-62.
10
Natural history of Southeast Asian chronic myeloid leukemia patients with different BCR-ABL gene variants.不同BCR-ABL基因变异的东南亚慢性髓性白血病患者的自然病史。
Acta Haematol. 2006;116(2):114-9. doi: 10.1159/000093641.

引用本文的文献

1
Identification of a novel cryptic variant chromosomal rearrangement involving 9q34, 22q11.2, and 5q22 resulting in ins(9;22) and t(5;22) in chronic myeloid leukemia: a case report.慢性髓性白血病中一种涉及9q34、22q11.2和5q22的新型隐匿性染色体重排的鉴定,导致ins(9;22)和t(5;22):一例报告
Ann Hematol. 2024 Dec;103(12):5963-5971. doi: 10.1007/s00277-024-05966-8. Epub 2024 Sep 27.
2
VNTR polymorphism in the breakpoint region of ABL1 and susceptibility to bladder cancer.ABL1 断点区域的 VNTR 多态性与膀胱癌易感性。
BMC Med Genomics. 2021 May 5;14(1):121. doi: 10.1186/s12920-021-00968-1.
3
Potential Role of Curcumin and Its Nanoformulations to Treat Various Types of Cancers.

本文引用的文献

1
Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells.从外显子组测序数据中挖掘被过继转移的肿瘤反应性 T 细胞识别的突变抗原。
Nat Med. 2013 Jun;19(6):747-52. doi: 10.1038/nm.3161. Epub 2013 May 5.
2
Cytogenetic & molecular analyses in adult chronic myelogenous leukaemia patients in north India.印度北部成人慢性髓性白血病患者的细胞遗传学和分子分析。
Indian J Med Res. 2012;135(1):42-8. doi: 10.4103/0971-5916.93423.
3
BCR-ABL mutations in chronic myeloid leukemia.慢性髓性白血病中的 BCR-ABL 突变。
姜黄素及其纳米制剂在治疗各类癌症中的潜在作用。
Biomolecules. 2021 Mar 7;11(3):392. doi: 10.3390/biom11030392.
Hematol Oncol Clin North Am. 2011 Oct;25(5):997-1008, v-vi. doi: 10.1016/j.hoc.2011.09.005.
4
Frequencies of BCR-ABL1 fusion transcripts among Sudanese chronic myeloid leukaemia patients.苏丹慢性髓性白血病患者中 BCR-ABL1 融合转录本的频率。
Genet Mol Biol. 2010 Apr;33(2):229-31. doi: 10.1590/S1415-47572010005000037. Epub 2010 Jun 1.
5
Candidate single nucleotide polymorphism markers for arsenic responsiveness of protein targets.蛋白质靶点砷反应性的候选单核苷酸多态性标记物。
Bioinform Biol Insights. 2010 Oct 11;4:99-111. doi: 10.4137/BBI.S5498.
6
Presence of a new BCR-ABL kinase domain mutation, C330G in an imatinib naive patient with chronic myeloid leukemia: very low prevalence of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia from eastern India.一名初治慢性髓性白血病患者中存在新的BCR-ABL激酶结构域突变C330G:印度东部慢性髓性白血病患者中BCR-ABL激酶结构域突变的极低发生率
Leuk Lymphoma. 2009 Apr;50(4):663-6. doi: 10.1080/10428190802714032.
7
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.世界卫生组织(WHO)髓系肿瘤和急性白血病分类的2008年修订版:基本原理及重要变化
Blood. 2009 Jul 30;114(5):937-51. doi: 10.1182/blood-2009-03-209262. Epub 2009 Apr 8.
8
Patterns of somatic mutation in human cancer genomes.人类癌症基因组中的体细胞突变模式。
Nature. 2007 Mar 8;446(7132):153-8. doi: 10.1038/nature05610.
9
e19a2 BCR-ABL fusion transcript in typical chronic myeloid leukaemia: a report of two cases.典型慢性髓性白血病中的e19a2 BCR-ABL融合转录本:两例报告
J Clin Pathol. 2006 Oct;59(10):1102-3. doi: 10.1136/jcp.2005.029595.
10
Molecular profiling of chronic myeloid leukemia in eastern India.印度东部慢性髓性白血病的分子特征分析
Am J Hematol. 2006 Nov;81(11):845-9. doi: 10.1002/ajh.20682.